Replimune
- Biotech or pharma, therapeutic R&D
Replimune's vision is to deliver transformational results for patients across cancers using tumor directed oncolytic immunotherapy to induce a powerful and durable systemic anti-tumor immune response resulting in quality survival and a chance for cure.